{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-007998","form_type":"8-K","ticker":"CTNM","cik":"0001855175","company_name":"Contineum Therapeutics, Inc.","filed_at":"2025-03-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.331220+00:00","generated_at":"2026-05-24T16:37:38.968640+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Contineum appoints Diego Miralles, M.D. to board of directors","bullets":["Dr. Miralles appointed as Class II director effective March 14, 2025, term expiring at 2026 annual meeting.","He previously served as an advisor under an agreement with monthly retainer of up to $16,000 and an option for 5,000 shares at $17.92.","As a non-employee director, he will receive standard cash and equity compensation including an initial option grant for 29,500 shares.","Dr. Miralles is not considered independent under Nasdaq listing standards.","He currently serves as CEO of AZURNA Therapeutics and serves on the board of Artiva Biotherapeutics."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-007998","json":"https://secwatch.observer/filing/0001437749-25-007998.json","markdown":"https://secwatch.observer/filing/0001437749-25-007998.md","text":"https://secwatch.observer/filing/0001437749-25-007998.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855175/000143774925007998/0001437749-25-007998-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855175/000143774925007998/cont20250304_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T16:37:38.968640+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a15cad9dbc","claim":"Diego Miralles, M.D. was appointed as Director at Contineum Therapeutics, Inc..","evidence_excerpt":"On March 14, 2025, the board of directors (the “Board”) of Contineum Therapeutics, Inc. (the “Company”) appointed Diego Miralles, M.D. as a member of its Board, effective March 14, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1855175/000143774925007998/0001437749-25-007998-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}